Edwards Lifesciences Corporation provided earnings guidance for the first quarter and full year 2024. For the first quarter of 2024, the company projects total sales to be between $1.53 billion and $1.61 billion.

For full year 2024, the company expects sales to grow 8% to 10% to $6.3 billion to $6.6 billion.